Share this
Travere Therapeutics – $316 Million Convertible Note Offering
Vuori Secures $400 Million Investment From SoftBank Vision Fund 2
Reneo Pharmaceuticals – $94 Million IPO
Mirum Inks $210 Million Funding Arrangement + Closes Follow-On Offering
Sazerac to Acquire Paul Masson Grande Amber Brandy From Constellation Brands
Neurocrine Partners With Takeda to Address Psychiatric Disorders
Sazerac to Acquire Whiskey Brands and Distillery From Brown-Forman
Cooley advises Ascus Biosciences on $46M Series B Round
Sazerac Acquires Beverage Brands from Diageo for 550 Million
Sazerac Investment in John Distilleries
Mirum Pharmaceuticals - $75 Million IPO
Neurocrine Biosciences, Inc: $290 Million Follow-On Offering
Competitor Group, Inc: Event and Acquisition Agreements for Rock 'n' Roll Marathon Series
Baby Tula LLC: $82 Million Sale to Compass Diversified Holdings
Sazerac to Acquire Southern Comfort + Tuaca for $544 Million
Retrophin, Inc: $245 Million Sale of Review Voucher to Sanofi
Celladon Initial Public Offering
Hot Topic $600 Million Sale to Sycamore Partners
Spruce Biosciences – $130 Million IPO